Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy
Cancers · 31.07.2025 · 17 (15) · 2534
DOI: 10.3390/cancers17152534 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 31.07.2025. Verfasst von Kezia Gitareja und 5 weiteren Autor:innen. Beteiligte Einrichtung: St. Vincent's Institute of Medical Research, Melbourne, VIC 3065, Australia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 326 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Future Fund 2023 Genomics Health Future Grant, MRFF 2023 Genomics Health Future, Tour de Cure and the Barrie Dalgleish Centre for Myeloma and Related Blood Cancers.
Abstract (Originalsprache)
Ribosome biogenesis is a highly coordinated, multi-step process that assembles the ribosomal machinery responsible for translating mRNAs into proteins. It begins with the rate-limiting step of RNA polymerase I (Pol I) transcription of the 47S ribosomal RNA (rRNA) genes within a specialised nucleolar region in the nucleus, followed by rRNA processing, modification, and assembly with ribosomal proteins and the 5S rRNA produced by Pol III. The ribosomal subunits are then exported to the cytoplasm to form functional ribosomes. This process is tightly regulated by the PI3K/RAS/MYC oncogenic network, which is frequently deregulated in many cancers. As a result, ribosome synthesis, mRNA translation, and protein synthesis rates are increased. Growing evidence supports the notion that dysregulation of ribosome biogenesis and mRNA translation plays a pivotal role in the pathogenesis of cancer, positioning the ribosome as a promising therapeutic target. In this review, we summarise current understanding of dysregulated ribosome biogenesis and function in cancer, evaluate the clinical development of ribosome targeting therapies, and explore emerging targets for therapeutic intervention in this rapidly evolving field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- St. Vincent's Institute of Medical Research, Melbourne, VIC 3065, Australia.
- Department of Medicine-St. Vincent's Hospital, University of Melbourne, Melbourne, VIC 3065, Australia.
- Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC 3800, Australia.
- Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3000, Australia.
- Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
ORCID-Profile: Shalini S Chelliah, Elaine Sanij, Shahneen Sandhu, Jian Kang, Amit Khot
Förderung
- Medical Research Future Fund 2023 Genomics Health Future Grant
- MRFF 2023 Genomics Health Future
- Tour de Cure and the Barrie Dalgleish Centre for Myeloma and Related Blood Cancers
- University of Melbourne and the Australian Commonwealth Government, Tour de Cure, and St Vincent’s Institute (SVI) Foundation
- Monash University and SVI Foundation
- 5Point Foundation (Christine Martin Fellowship)
Zitieren
APA
Gitareja, K., Chelliah, S. S., Sanij, E., Sandhu, S., Kang, J., & Khot, A. (2025). Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy. Cancers, 17(15), 2534. https://doi.org/10.3390/cancers17152534
Vancouver
Gitareja K, Chelliah SS, Sanij E, Sandhu S, Kang J, Khot A. Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy. Cancers. 2025;17(15):2534. doi:10.3390/cancers17152534
BibTeX
@article{Gitareja2025,
author = {Gitareja, Kezia and Chelliah, Shalini S and Sanij, Elaine and Sandhu, Shahneen and Kang, Jian and Khot, Amit},
title = {Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy},
journal = {Cancers},
year = {2025},
volume = {17},
number = {15},
pages = {2534},
doi = {10.3390/cancers17152534}
}
EUVIMED